BLTE
Belite Bio Inc ADR
NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY
$154.50
-2.66% today
Updated 2026-04-29
Market cap
$6.17B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.32
Dividend yield
—
52W range
$56 – $200
Volume
0.2M
Belite Bio Inc ADR (BLTE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | $17000.00 | $30000.00 | $198000.00 | $399000.00 | $449000.00 | — |
| Gross profit | $-17000.00 | $-30000.00 | $-198000.00 | $-399000.00 | $-449000.00 | — |
| Gross margin | — | — | — | — | — | — |
| R&D | $3.69M | $7.42M | $8.87M | $24.84M | $29.94M | $45.38M |
| SG&A | $2.06M | $2.38M | $3.95M | $6.82M | $10.06M | $38.83M |
| Operating income | $-5.74M | $-9.80M | $-12.82M | $-31.67M | $-40.00M | $-84.21M |
| Operating margin | — | — | — | — | — | — |
| EBITDA | $-5.73M | $-9.64M | $-12.43M | $-31.20M | $-35.67M | $-84.21M |
| EBITDA margin | — | — | — | — | — | — |
| EBIT | $-5.74M | $-9.67M | $-12.63M | $-31.60M | $-36.12M | — |
| Interest expense | $21000.00 | $5000.00 | $16000.00 | $25000.00 | $20000.00 | $2000.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.75M | $-9.67M | $-12.65M | $-31.63M | $-36.14M | $-77.61M |
| Net income growth (YoY) | — | -68.0% | -30.9% | -150.1% | -14.3% | -114.7% |
| Profit margin | — | — | — | — | — | — |